Completed PHASE4 INTERVENTIONAL 2-arm NCT02897206

Imipenem Prophylaxis in Patients With Acute Pancreatitis (IMPROWE)

Imipenem Prophylaxis of Infectious Complications in Patients With Acute Pancreatitis

Sponsor: University Hospital Rijeka

Updated 7 times since 2017 Last updated: Jun 18, 2017 Started: Oct 31, 2014 Primary completion: Dec 31, 2016 Completion: Dec 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Acute Pancreatitis, this trial is completed. The trial is conducted by University Hospital Rijeka and has accumulated 7 data snapshots since 2014. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jul 2017 — Jun 2018 [monthly]

Completed PHASE4

Status: Recruiting → Completed

▶ Show 2 earlier versions

Feb 2017 — Jul 2017 [monthly]

Recruiting PHASE4
Jan 2017 — Feb 2017 [monthly]

Recruiting PHASE4

First recorded

Oct 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University Hospital Rijeka
University of Rijeka

Data source: University Hospital Rijeka

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Rijeka, Croatia